Shashikant V. Bhandari

921 total citations
44 papers, 747 citations indexed

About

Shashikant V. Bhandari is a scholar working on Organic Chemistry, Computational Theory and Mathematics and Molecular Biology. According to data from OpenAlex, Shashikant V. Bhandari has authored 44 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Organic Chemistry, 14 papers in Computational Theory and Mathematics and 10 papers in Molecular Biology. Recurrent topics in Shashikant V. Bhandari's work include Synthesis and biological activity (26 papers), Computational Drug Discovery Methods (14 papers) and Inflammatory mediators and NSAID effects (6 papers). Shashikant V. Bhandari is often cited by papers focused on Synthesis and biological activity (26 papers), Computational Drug Discovery Methods (14 papers) and Inflammatory mediators and NSAID effects (6 papers). Shashikant V. Bhandari collaborates with scholars based in India, United States and Japan. Shashikant V. Bhandari's co-authors include Kailash G. Bothara, Aniket P. Sarkate, Ajit Patil, Vinod Mokale, Deepak K. Lokwani, Trupti S. Chitre, Vidya Pawar, Nisheeth C. Desai, Prashant J. Burange and Ashwini Madgulkar and has published in prestigious journals such as Journal of the American Chemical Society, Tetrahedron and Organic Letters.

In The Last Decade

Shashikant V. Bhandari

40 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shashikant V. Bhandari India 13 631 154 107 90 72 44 747
Kailash G. Bothara India 13 594 0.9× 136 0.9× 118 1.1× 65 0.7× 69 1.0× 22 768
Osama I. El‐Sabbagh Egypt 14 645 1.0× 168 1.1× 76 0.7× 65 0.7× 37 0.5× 27 753
Ahmet Çağrı Karaburun Türkiye 14 615 1.0× 179 1.2× 150 1.4× 97 1.1× 33 0.5× 28 718
Anelia Ts. Mavrova Bulgaria 16 776 1.2× 215 1.4× 45 0.4× 80 0.9× 80 1.1× 36 937
Sumit Tahlan India 15 586 0.9× 180 1.2× 54 0.5× 84 0.9× 65 0.9× 19 746
Gülgün Ayhan‐Kılcıgil Türkiye 15 788 1.2× 180 1.2× 72 0.7× 107 1.2× 66 0.9× 39 893
Omprakash Tanwar India 15 673 1.1× 233 1.5× 97 0.9× 139 1.5× 61 0.8× 25 909
Mai E. Shoman Egypt 17 451 0.7× 245 1.6× 84 0.8× 80 0.9× 62 0.9× 40 759
Sevil Şenkardeş Türkiye 9 602 1.0× 146 0.9× 88 0.8× 77 0.9× 51 0.7× 23 715
Birsen Tozkoparan Türkiye 15 1.1k 1.7× 202 1.3× 122 1.1× 46 0.5× 52 0.7× 52 1.2k

Countries citing papers authored by Shashikant V. Bhandari

Since Specialization
Citations

This map shows the geographic impact of Shashikant V. Bhandari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shashikant V. Bhandari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shashikant V. Bhandari more than expected).

Fields of papers citing papers by Shashikant V. Bhandari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shashikant V. Bhandari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shashikant V. Bhandari. The network helps show where Shashikant V. Bhandari may publish in the future.

Co-authorship network of co-authors of Shashikant V. Bhandari

This figure shows the co-authorship network connecting the top 25 collaborators of Shashikant V. Bhandari. A scholar is included among the top collaborators of Shashikant V. Bhandari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shashikant V. Bhandari. Shashikant V. Bhandari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhandari, Shashikant V., et al.. (2025). Integrated Computational Approach for Designing Potent EGFR‐TK Inhibitors: QSAR, Docking, ADMET, and Molecular Dynamics Studies. Chemistry & Biodiversity. 22(6). e202403150–e202403150. 1 indexed citations
2.
Isono, K., Hideaki Takano, Juwon Oh, et al.. (2025). Antiaromatic Nanographenes via a BODIPY-Fusion Strategy. Journal of the American Chemical Society. 147(49). 45441–45451. 1 indexed citations
3.
Bhandari, Shashikant V., Shigeki Mori, Daisuke Kawaguchi, et al.. (2025). Anion-Mediated Synthesis of Diethynyl-Substituted Doubly N-Confused Dioxohexaphyrin Dyes That Exhibit Enhanced Photoacoustic Signals in the NIR-II Region. Organic Letters. 27(26). 7218–7223. 1 indexed citations
4.
Bhandari, Shashikant V., et al.. (2025). Recent advancement on metal free hydroamination reaction of C–C multiple bonds. Tetrahedron. 179. 134625–134625. 1 indexed citations
7.
Bhandari, Shashikant V., et al.. (2024). Applications of samarium complexes as cytotoxic, bioimaging and DNA interacting agents: a comprehensive review. Reviews in Inorganic Chemistry. 44(3). 377–383.
8.
Bhandari, Shashikant V., et al.. (2024). Rational Drug Discovery for Isoxazole Based VEGFR2 Inhibition. Current Drug Discovery Technologies. 22(2). e240524230316–e240524230316. 1 indexed citations
9.
10.
Bhandari, Shashikant V., et al.. (2023). Molecular Docking, Pharmacokinetic and Molecular Simulation Analysis of Novel Mono‐Carbonyl Curcumin Analogs as L858R/T790M/C797S Mutant EGFR Inhibitors. Chemistry & Biodiversity. 20(11). e202301081–e202301081. 6 indexed citations
12.
Sarkate, Aniket P., Shailee V. Tiwari, Deepak K. Lokwani, et al.. (2021). One pot synthesis, in silico study and evaluation of some novel flavonoids as potent topoisomerase II inhibitors. Bioorganic & Medicinal Chemistry Letters. 40. 127916–127916. 9 indexed citations
13.
Bhandari, Shashikant V., et al.. (2017). 2D, 3D, G-QSAR and Docking Studies of Thiazolyl-pyrazoline Analogues as Potent (Epidermal Growth Factor Receptor-tyrosine Kinase) EGFR-TK Inhibitors. Letters in Drug Design & Discovery. 14(11). 1228–1238. 6 indexed citations
14.
Bhalgat, Chetan M., et al.. (2014). Synthesis and pharmacological screening of some novel anti-hypertensive agents possessing 5-Benzylidene-2-(phenylimino)-thiazolidin-4-one ring. European Journal of Medicinal Chemistry. 76. 580–588. 28 indexed citations
16.
Bhandari, Shashikant V., Kailash G. Bothara, Trupti S. Chitre, et al.. (2010). Design, synthesis, and evaluation of anti-inflammatory, analgesic, ulcerogenicity, and nitric oxide releasing studies of novel indomethacin analogs as non-ulcerogenic derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry. 25(4). 520–530. 27 indexed citations
17.
Bhandari, Shashikant V., et al.. (2009). Design, synthesis and pharmacological screening of novel nitric oxide donors containing 1,5-diarylpyrazolin-3-one as nontoxic NSAIDs. European Journal of Medicinal Chemistry. 44(11). 4622–4636. 30 indexed citations
18.
Bhandari, Shashikant V., et al.. (2008). A REVIEW ON PHYTOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF MOMORDICA CHARANTIA LINN.. 2 indexed citations
19.
Bhandari, Shashikant V., et al.. (2008). Design, Synthesis and Pharmacological Screening of Novel Antihypertensive Agents Using Hybrid Approach. Bioorganic & Medicinal Chemistry. 17(1). 390–400. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026